Skip to main content
Retour
HQH logo

Abrdn Healthcare Investors

Qualité des données : 100%
HQH
NYSE Financial Services Asset Management
17,75 €
▲ 0,06 € (0,34%)
Cap. Boursière : 956,05M
Fourchette du Jour
17,70 € 18,06 €
Fourchette 52 Semaines
13,77 € 20,46 €
Volume
134 083
Moyenne 50J / 200J
19,06 € / 17,81 €
Clôture Précédente
17,69 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Financial Services (854 pairs)

Métrique Action Médiane du Secteur
P/E 9,7 10,3
P/B 0,9 1,1
ROE % 9,2 11,7
Net Margin % 98,8 16,8
Rev Growth 5Y % 98,1 11,7
D/E 0,0 0,5

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Points Clés

Revenue grew 98,11% annually over 5 years — strong growth
Earnings declined -46,68% over the past year
Net margin of 98,80% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of 0,0
P/E of 9,69 — trading at a low valuation

Croissance

Revenue Growth (5Y)
98,11%
Revenue (1Y)826,84%
Earnings (1Y)-46,68%
FCF Growth (3Y)N/A

Qualité

Return on Equity
9,16%
ROIC6,76%
Net Margin98,80%
Op. Margin98,80%

Sécurité

Debt / Equity
0,00
Current Ratio2,15
Interest Coverage0,00

Valorisation

P/E Ratio
9,69
P/B Ratio0,87
EV/EBITDA9,69
Dividend Yield0,12%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 826,84% Revenue Growth (3Y) 211,42%
Earnings Growth (1Y) -46,68% Earnings Growth (3Y) 32,31%
Revenue Growth (5Y) 98,11% Earnings Growth (5Y) -10,72%
Profitability
Revenue (TTM) 99,81M Net Income (TTM) 98,61M
ROE 9,16% ROA 8,99%
Gross Margin 100,00% Operating Margin 98,80%
Net Margin 98,80% Free Cash Flow (TTM) 0,0
ROIC 6,76% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 2,15
Interest Coverage 0,00 Dividend Yield 0,12%
Valuation
P/E Ratio 9,69 P/B Ratio 0,87
P/S Ratio 9,58 PEG Ratio -0,21
EV/EBITDA 9,69 Dividend Yield 0,12%
Market Cap 956,05M Enterprise Value 956,05M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 99,81M 10,77M 10,29M 8,27M 6,48M
Net Income 98,61M 184,95M 56,33M -194,23M 155,18M
EPS (Diluted) 1,84 3,55 1,14 -4,10 3,49
Gross Profit 99,81M 10,77M 10,29M 8,27M 6,48M
Operating Income 98,61M -220 271,0 -1,19M -3,67M -6,23M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,10B 1,06B 932,49M 926,28M 1,17B
Total Liabilities 3,43M 1,40M 1,15M 9,71M 15,63M
Shareholders' Equity 1,09B 1,06B 931,34M 916,56M 1,16B
Total Debt 0,0 0,0 0,0 8,50M 11,33M
Cash & Equivalents 59,0 56,0 214,0 792,0 935,0
Current Assets 2,61M 603 882,0 39,64M 42,71M 12,40M
Current Liabilities 1,21M 1,40M 1,15M 9,71M 15,63M

Scores de Stratégies

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches

Activité Récente

Entré Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré Defensive Investing (Benjamin Graham)
Mar 24, 2026